Author

Sarasa A. Mohammadi

The University of SydneyORCID 0000-0002-8351-8635Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Ada QuinniD· 1 shared Anna E. TischeriD· 1 shared Azadeh ShahsavariD· 1 shared Billy J. Williams‐NoonaniD· 1 shared Christopher L. CioffiiD· 1 shared Irina LotsarisiD· 1 shared Julian Peiser-OliveriD· 1 shared Karin R. AubreyiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Ada QuinnORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A reversible allosteric inhibitor of GlyT2 alleviates neuropathic pain without on-target side effects

Ryan Cantwell Chater, Julian Peiser-Oliver, Tanmay K. Pati, Ada Quinn, Irina Lotsaris, Zachary J. Frangos, Kristen E. Anderson, Anna E. Tischer, Billy J. Williams‐Noonan, Karin R. Aubrey, Megan L. O’Mara, Michael Michaelides, Sarasa A. Mohammadi, Christopher L. Cioffi, Robert J. Vandenberg, Azadeh Shahsavar

This paper develops a reversible GlyT2 inhibitor that alleviates neuropathic pain without on-target side effects or addiction liability.

bioRxiv · Apr 21, 2025 · PreprintNeuroscience